chrX-2949663-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000047.3(ARSL):​c.495T>C​(p.His165His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.017 in 1,209,964 control chromosomes in the GnomAD database, including 157 homozygotes. There are 6,518 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 11 hom., 383 hem., cov: 22)
Exomes 𝑓: 0.017 ( 146 hom. 6135 hem. )

Consequence

ARSL
NM_000047.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.782

Publications

1 publications found
Variant links:
Genes affected
ARSL (HGNC:719): (arylsulfatase L) Arylsulfatase E is a member of the sulfatase family. It is glycosylated postranslationally and localized to the golgi apparatus. Sulfatases are essential for the correct composition of bone and cartilage matrix. X-linked chondrodysplasia punctata, a disease characterized by abnormalities in cartilage and bone development, has been linked to mutations in this gene. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on the Y chromosome. [provided by RefSeq, Sep 2013]
ARSL Gene-Disease associations (from GenCC):
  • X-linked chondrodysplasia punctata 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant X-2949663-A-G is Benign according to our data. Variant chrX-2949663-A-G is described in ClinVar as Benign. ClinVar VariationId is 516293.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.782 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0128 (1427/111890) while in subpopulation NFE AF = 0.0188 (1000/53169). AF 95% confidence interval is 0.0178. There are 11 homozygotes in GnomAd4. There are 383 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARSLNM_000047.3 linkc.495T>C p.His165His synonymous_variant Exon 6 of 11 ENST00000381134.9 NP_000038.2 P51690

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARSLENST00000381134.9 linkc.495T>C p.His165His synonymous_variant Exon 6 of 11 1 NM_000047.3 ENSP00000370526.3 P51690

Frequencies

GnomAD3 genomes
AF:
0.0128
AC:
1428
AN:
111833
Hom.:
11
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00221
Gnomad AMI
AF:
0.129
Gnomad AMR
AF:
0.00590
Gnomad ASJ
AF:
0.0309
Gnomad EAS
AF:
0.000281
Gnomad SAS
AF:
0.00486
Gnomad FIN
AF:
0.0155
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0188
Gnomad OTH
AF:
0.0139
GnomAD2 exomes
AF:
0.0134
AC:
2450
AN:
182878
AF XY:
0.0129
show subpopulations
Gnomad AFR exome
AF:
0.00213
Gnomad AMR exome
AF:
0.00358
Gnomad ASJ exome
AF:
0.0336
Gnomad EAS exome
AF:
0.0000722
Gnomad FIN exome
AF:
0.0174
Gnomad NFE exome
AF:
0.0196
Gnomad OTH exome
AF:
0.0152
GnomAD4 exome
AF:
0.0174
AC:
19149
AN:
1098074
Hom.:
146
Cov.:
32
AF XY:
0.0169
AC XY:
6135
AN XY:
363432
show subpopulations
African (AFR)
AF:
0.00133
AC:
35
AN:
26401
American (AMR)
AF:
0.00395
AC:
139
AN:
35200
Ashkenazi Jewish (ASJ)
AF:
0.0333
AC:
646
AN:
19381
East Asian (EAS)
AF:
0.0000993
AC:
3
AN:
30204
South Asian (SAS)
AF:
0.00623
AC:
337
AN:
54089
European-Finnish (FIN)
AF:
0.0175
AC:
710
AN:
40528
Middle Eastern (MID)
AF:
0.00484
AC:
20
AN:
4135
European-Non Finnish (NFE)
AF:
0.0196
AC:
16540
AN:
842044
Other (OTH)
AF:
0.0156
AC:
719
AN:
46092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
850
1700
2551
3401
4251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
634
1268
1902
2536
3170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0128
AC:
1427
AN:
111890
Hom.:
11
Cov.:
22
AF XY:
0.0112
AC XY:
383
AN XY:
34056
show subpopulations
African (AFR)
AF:
0.00221
AC:
68
AN:
30837
American (AMR)
AF:
0.00589
AC:
62
AN:
10518
Ashkenazi Jewish (ASJ)
AF:
0.0309
AC:
82
AN:
2653
East Asian (EAS)
AF:
0.000282
AC:
1
AN:
3545
South Asian (SAS)
AF:
0.00449
AC:
12
AN:
2670
European-Finnish (FIN)
AF:
0.0155
AC:
94
AN:
6078
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.0188
AC:
1000
AN:
53169
Other (OTH)
AF:
0.0138
AC:
21
AN:
1526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
55
109
164
218
273
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0172
Hom.:
130
Bravo
AF:
0.0115

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 07, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Chondrodysplasia punctata, brachytelephalangic, autosomal Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

X-linked chondrodysplasia punctata 1 Benign:1
Oct 23, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Connective tissue disorder Benign:1
Dec 22, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.24
DANN
Benign
0.33
PhyloP100
-0.78
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35274634; hg19: chrX-2867704; API